Samuel Waksal, PhD
Home
About Us
Structure
Current Events
Past Events
Video Gallery
Policy & Reports
Awards
Membership
Media Coverage
Internship/Volunteers
Legal
Contact Us
 
 
Samuel Waksal, PhD
Founder
Meira GTx

Dr. Waksal was the founder and former President and CEO of ImClone Systems, developer of Erbitux, one of the top-selling cancer drugs in the world, as well as Cyramza, the first anti-VEGFR-2 antibody. In 2008, ImClone Systems was sold to Eli Lilly & Company for $7 billion. Dr. Waksal is responsible for four antibodies, which are on the market globally in the cancer field and many others now in clinical trials.

Dr. Waksal was also the founder of one of the early gene therapy companies, Merlin, which was a core part of one of the earliest gene therapy companies, Somatix. Dr. Waksal was a founding director of Medicis Pharmaceuticals, a dermatology company, which was sold to Valeant in 2013.

Dr. Waksal is also the founder of Meira GTx a London, England and New York City based gene therapy company. Meira GTx is a world leader in the field of Gene Regulation, Ocular Gene Therapy, xerostomia, and Neurodegeneration. It has recently established a joint development deal with Janssen Pharmaceuticals (a division of Johnson & Johnson), in the field of inherited eye disease.

Sam Waksal is the Founder, and was Chairman and CEO until January of 2016, of Kadmon Corporation, a privately held, New York City-based biopharmaceutical company. Collaborating with academic centers and private enterprise at the forefront of innovation, Kadmon is focused on pioneering medicines in the areas of oncology, infectious diseases, immunology and metabolic diseases, building from its commercial platform in hepatology and genetic diseases.

Dr. Waksal currently serves as a Visiting Fellow in Neuroscience at Weil Cornell Medical College, Feil Family Brain and Mind Research Institute in New York City.

Dr. Waksal spent the first half of his career in academic medicine. He was a professor of pathology and the director of the Division of Immunotherapy at the Mount Sinai School of Medicine in New York. He also served as visiting investigator at the National Cancer Institute, Immunology Branch, a research associate in the Department of Genetics at Stanford University Medical School, an assistant professor at Tufts University School of Medicine and a senior scientist at the Tufts Cancer Research Center. Dr. Waksal was a scholar of the Leukemia Society of America and has been a visiting professor at the Pasteur Institute in France and the Weizmann Institute of Science in Israel. He was also a member of the Board of Advisors of Rockefeller University. Dr. Waksal has published over 60 papers in such journals as Cell and Nature as well as chapters in books. He is also the recipient of numerous patents globally in the areas of cancer and immunology. For almost 15 years Dr. Waksal was the Chairman of the New York State Council for the Humanities where he was appointed by the Governor of New York State. Dr. Waksal has served as a board member for several public and private companies. He is also a regular guest host on CNBC’s Squawkbox.

© 2007 - USA India Chamber of Commerce Home | About us | | Policy | Events | Photo Gallery | Awards | Membership | Media Coverage | | Legal | Contact us